Operational KPIs
No quarterly operational KPIs found in SEC filings for this company.
Citable operating metrics
DHR's latest SEC-sourced operating KPI table includes Base Business Core Sales Growth at -19.00 for 2023-12-31.
| Metric | Period | Value | Basis |
|---|---|---|---|
| Base Business Core Sales Growth | Dec 31, 2023 | -19.00 | quarterly |
| Base Business Core Sales Growth Non Gaap | Mar 31, 2026 | 1.45 | quarterly |
| Core Sales Growth | Dec 31, 2025 | -1.00 | quarterly |
| Core Sales Growth Diagnostics | Dec 31, 2025 | 2720.00 | quarterly |
| Core Sales Growth Including Cytiva | Mar 31, 2021 | 29.00 | quarterly |
| Core Sales Growth Life Sciences | Dec 31, 2025 | 2085.00 | quarterly |
| Core Sales Growth Non Gaap | Mar 31, 2026 | 1.45 | quarterly |
| Core Sales Growth Non Gaap Diagnostics | Dec 31, 2025 | 2720.00 | quarterly |
Source: SEC EDGAR operating KPI disclosure; period Dec 31, 2023; filed Jan 30, 2024; accession 0000313616-24-000006.
Continue research
Follow same-sector companies and source explainers connected to the kpis view.
A factual guide to operating KPIs — the company-specific metrics in filings, why they are not standardized, and how Aerarium Research surfaces them.
A factual guide to deferred revenue, cash collected before revenue is earned, and why the liability can matter for recurring businesses.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to seasonal revenue patterns and comparable (same-store) sales — why year-over-year comparisons matter and what comp sales strip out.